Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy

Autophagy

Volumn 12, Issue 10, 2016, Pages 1791-1803

  Wang, Juan ^a   Zhou, Jun Ying ^a   Kho, Dhonghyo ^a   Reiners, John J ^a,b   Wu, Gen Sheng ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

autophagy; cisplatin resistance; DUSP1; MAPK ERK; ovarian cancer

Indexed keywords

AUTOPHAGY PROTEIN 14; AUTOPHAGY PROTEIN 5; BECLIN 1; CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; RAPAMYCIN; SERINE; SHORT HAIRPIN RNA; ULK1 PROTEIN; UNCLASSIFIED DRUG; DUSP1 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; MULTIPROTEIN COMPLEX; SEQUESTOSOME 1; SQSTM1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER RESISTANCE; CONTROLLED STUDY; CYTOSTASIS; FEMALE; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; PROTEIN PHOSPHORYLATION; SENSITIZATION; ANIMAL; DRUG EFFECTS; DRUG RESISTANCE; GENE SILENCING; KNOCKOUT MOUSE; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; AUTOPHAGOSOMES; AUTOPHAGY; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DUAL SPECIFICITY PHOSPHATASE 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; OVARIAN NEOPLASMS; SEQUESTOSOME-1 PROTEIN; SIROLIMUS;

EID: 84983504594     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2016.1203483     Document Type: Article

References (65)

1. D.J.Klionsky. Autophagy:from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8:931-7; PMID:17712358; http://dx.doi.org/10.1038/nrm2245
2. D.J.Klionsky, H.Abeliovich, P.Agostinis, D.K.Agrawal, G.Aliev, D.S.Askew, M.Baba, E.H.Baehrecke, B.A.Bahr, A.Ballabio, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4:151-75; PMID:18188003; http://dx.doi.org/10.4161/auto.5338
3. F.Scarlatti, R.Maffei, I.Beau, P.Codogno, R.Ghidoni. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008; 15:1318-29; PMID:18421301; http://dx.doi.org/10.1038/cdd.2008.51
4. D.Denton, S.Nicolson, S.Kumar. Cell death by autophagy:facts and apparent artefacts. Cell Death Differ 2012; 19:87-95; PMID:22052193; http://dx.doi.org/10.1038/cdd.2011.146
5. X.Sui, R.Chen, Z.Wang, Z.Huang, N.Kong, M.Zhang, W.Han, F.Lou, J.Yang, Q.Shang, et al. Autophagy and chemotherapy resistance:a promising therapeutic target for cancer treatment. Cell Death Dis 2013; 4:e838; PMID:24113172; http://dx.doi.org/10.1038/cddis.2013.350
6. F.Aredia, L.M.G.Ortiz, V.Giansanti, A.I.Scovassi. Autophagy and cancer. Cells 2012; 1:520-34; PMID:24710488; http://dx.doi.org/10.3390/cells1030520
7. R.Mathew, S.Kongara, B.Beaudoin, C.M.Karp, K.Bray, K.Degenhardt, G.Chen, S.Jin, E.White. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007; 21:1367-81; PMID:17510285; http://dx.doi.org/10.1101/gad.1545107
8. R.Mathew, C.M.Karp, B.Beaudoin, N.Vuong, G.Chen, H.Y.Chen, K.Bray, A.Reddy, G.Bhanot, C.Gelinas, et al. Autophagy suppresses tumorigenesis through elimination of P62. Cell 2009; 137:1062-75; PMID:19524509; http://dx.doi.org/10.1016/j.cell.2009.03.048
9. Z.Yue, S.Jin, C.Yang, A.J.Levine, N.Heintz. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003; 100:15077-82; PMID:14657337; http://dx.doi.org/10.1073/pnas.2436255100
10. U.E.Martinez-Outschoorn, C.Trimmer, Z.Lin, D.Whitaker-Menezes, B.Chiavarina, J.Zhou, C.Wang, S.Pavlides, M.P.Martinez-Cantarin, F.Capozza, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival:Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle 2010; 9:3515-33; PMID:20855962; http://dx.doi.org/10.4161/cc.9.17.12928
11. B.Chiavarina, D.Whitaker-Menezes, G.Migneco, U.E.Martinez-Outschoorn, S.Pavlides, A.Howell, H.B.Tanowitz, M.C.Casimiro, C.Wang, R.G.Pestell, et al. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells:Autophagy drives compartment-specific oncogenesis. Cell Cycle 2010; 9:3534-51; PMID:20864819; http://dx.doi.org/10.4161/cc.9.17.12908
12. R.J.Davis. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103:239-52; PMID:11057897; http://dx.doi.org/10.1016/S0092-8674(00)00116-1
13. G.L.Johnson, R.Lapadat. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298:1911-2; PMID:12471242; http://dx.doi.org/10.1126/science.1072682
14. G.Pearson, F.Robinson, T.Beers Gibson, B.E.Xu, M.Karandikar, K.Berman, M.H.Cobb. Mitogen-activated protein (MAP) kinase pathways:regulation and physiological functions. Endocr Rev 2001; 22:153-83; PMID:11294822
15. L.Chang, M.Karin. Mammalian MAP kinase signalling cascades. Nature 2001; 410:37-40; PMID:11242034; http://dx.doi.org/10.1038/35065000
16. N.J.Kennedy, R.J.Davis. Role of JNK in tumor development. Cell Cycle 2003; 2:199-201; PMID:12734425
17. J.F.Moruno-Manchon, E.Perez-Jimenez, E.Knecht. Glucose induces autophagy under starvation conditions by a p38 MAPK-dependent pathway. Biochem J 2013; 449:497-506; PMID:23116132; http://dx.doi.org/10.1042/BJ20121122
18. T.Matsuzawa, B.H.Kim, A.R.Shenoy, S.Kamitani, M.Miyake, J.D.Macmicking. IFN-gamma elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol 2012; 189:813-8; PMID:22675202; http://dx.doi.org/10.4049/jimmunol.1102041
19. S.Pattingre, C.Bauvy, P.Codogno. Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. The J Biol Chem 2003; 278:16667-74; PMID:12609989; http://dx.doi.org/10.1074/jbc.M210998200
20. R.J.Dickinson, S.M.Keyse. Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 2006; 119:4607-15; PMID:17093265; http://dx.doi.org/10.1242/jcs.03266
21. L.F.Lau, D.Nathans. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 1985; 4:3145-51; PMID:3841511
22. C.H.Charles, A.S.Abler, L.F.Lau. cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene 1992; 7:187-90; PMID:1741163
23. S.M.Keyse, E.A.Emslie. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 1992; 359:644-7; PMID:1406996; http://dx.doi.org/10.1038/359644a0
24. Y.Liu, M.Gorospe, C.Yang, N.J.Holbrook. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J Biol Chem 1995; 270:8377-80; PMID:7721728; http://dx.doi.org/10.1074/jbc.270.15.8377
25. H.Sun, C.H.Charles, L.F.Lau, N.K.Tonks. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993; 75:487-93; PMID:8221888; http://dx.doi.org/10.1016/0092-8674(93)90383-2
26. T.Noguchi, R.Metz, L.Chen, M.G.Mattei, D.Carrasco, R.Bravo. Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol Cell Biol 1993; 13:5195-205; PMID:8355678; http://dx.doi.org/10.1128/MCB.13.9.5195
27. C.C.Franklin, A.S.Kraft. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 1997; 272:16917-23; PMID:9202001; http://dx.doi.org/10.1074/jbc.272.27.16917
28. J.M.Brondello, F.R.McKenzie, H.Sun, N.K.Tonks, J.Pouyssegur. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 1995; 10:1895-904; PMID:7761091
29. G.S.Wu. The functional interactions between the p53 and MAPK signaling pathways. Cancer Bio Ther 2004; 3:156-61; PMID:14764989; http://dx.doi.org/10.4161/cbt.3.2.614
30. M.Li, J.Y.Zhou, Y.Ge, L.H.Matherly, G.S.Wu. The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. J Biol Chem 2003; 278:41059-68; PMID:12890671; http://dx.doi.org/10.1074/jbc.M307149200
31. C.C.Franklin, S.Srikanth, A.S.Kraft. Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc Natl Acad Sci USA 1998; 95:3014-9; PMID:9501207; http://dx.doi.org/10.1073/pnas.95.6.3014
32. I.Sanchez-Perez, M.Martinez-Gomariz, D.Williams, S.M.Keyse, R.Perona. CL100/MKP-1 JNK activation and apoptosis in response to cisplatin. Oncogene 2000; 19:5142-52; PMID:11064451; http://dx.doi.org/10.1038/sj.onc.1203887
33. S.Chattopadhyay, R.Machado-Pinilla, C.Manguan-Garcia, C.Belda-Iniesta, C.Moratilla, P.Cejas, J.A.Fresno-Vara, J.de Castro-Carpeno, E.Casado, M.Nistal, et al. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Oncogene 2006; 25:3335-45; PMID:16462770; http://dx.doi.org/10.1038/sj.onc.1209364
34. H.Y.Wang, Z.Cheng, C.C.Malbon. Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett 2003; 191:229-37; PMID:12618338; http://dx.doi.org/10.1016/S0304-3835(02)00612-2
35. G.S.Wu. Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer Metastasis Rev 2007; 26:579-85; PMID:17717636; http://dx.doi.org/10.1007/s10555-007-9079-6
36. F.Rojo, I.Gonzalez-Navarrete, R.Bragado, A.Dalmases, S.Menendez, M.Cortes-Sempere, C.Suarez, C.Oliva, S.Servitja, V.Rodriguez-Fanjul, et al. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin. Clin Cancer Res 2009; 15:3530-9; PMID:19417026; http://dx.doi.org/10.1158/1078-0432.CCR-08-2070
37. Z.Wang, J.Xu, J.Y.Zhou, Y.Liu, G.S.Wu. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. Cancer Res 2006; 66:8870-7; PMID:16951204; http://dx.doi.org/10.1158/0008-5472.CAN-06-1280
38. J.Wang, J.Y.Zhou, G.S.Wu. ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells. Cancer Res 2007; 67:11933-41; PMID:18089824; http://dx.doi.org/10.1158/0008-5472.CAN-07-5185
39. B.Raught, A.C.Gingras, N.Sonenberg. The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A 2001; 98:7037-44; PMID:11416184; http://dx.doi.org/10.1073/pnas.121145898
40. J.Wang, G.S.Wu. Role of autophagy in cisplatin resistance in ovarian cancer cells. J Biol Chem 2014; 289:17163-73; PMID:24794870; http://dx.doi.org/10.1074/jbc.M114.558288
41. A.Yamamoto, Y.Tagawa, T.Yoshimori, Y.Moriyama, R.Masaki, Y.Tashiro. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 1998; 23:33-42; PMID:9639028; http://dx.doi.org/10.1247/csf.23.33
42. S.M.Keyse. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev 2008; 27:253-61; PMID:18330678; http://dx.doi.org/10.1007/s10555-008-9123-1
43. R.C.Russell, Y.Tian, H.Yuan, H.W.Park, Y.Y.Chang, J.Kim, H.Kim, T.P.Neufeld, A.Dillin, K.L.Guan. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 2013; PMID:23685627
44. S.Alers, A.S.Loffler, S.Wesselborg, B.Stork. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy:cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012; 32:2-11; PMID:22025673; http://dx.doi.org/10.1128/MCB.06159-11
45. W.Tian, W.Li, Y.Chen, Z.Yan, X.Huang, H.Zhuang, W.Zhong, Y.Chen, W.Wu, C.Lin, et al. Phosphorylation of ULK1 by AMPK regulates translocation of ULK1 to mitochondria and mitophagy. FEBS Lett 2015; 589:1847-54; PMID:25980607; http://dx.doi.org/10.1016/j.febslet.2015.05.020
46. A.I.Fogel, B.J.Dlouhy, C.Wang, S.W.Ryu, A.Neutzner, S.A.Hasson, D.P.Sideris, H.Abeliovich, R.J.Youle. Role of membrane association and Atg14-dependent phosphorylation in beclin-1-mediated autophagy. Mol Cell Biol 2013; 33:3675-88; PMID:23878393; http://dx.doi.org/10.1128/MCB.00079-13
47. J.Wang, J.Y.Zhou, L.Zhang, G.S.Wu. Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells. Cell Cycle 2009; 8:3191-8; PMID:19755862; http://dx.doi.org/10.4161/cc.8.19.9751
48. J.Wang, M.W.Whiteman, H.Lian, G.Wang, A.Singh, D.Huang, T.Denmark. A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. J Biol Chem 2009; 284:21412-24; PMID:19520853; http://dx.doi.org/10.1074/jbc.M109.026013
49. E.Corcelle, M.Nebout, S.Bekri, N.Gauthier, P.Hofman, P.Poujeol, P.Fenichel, B.Mograbi. Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Res 2006; 66:6861-70; PMID:16818664; http://dx.doi.org/10.1158/0008-5472.CAN-05-3557
50. Y.Wei, S.Pattingre, S.Sinha, M.Bassik, B.Levine. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 2008; 30:678-88; PMID:18570871; http://dx.doi.org/10.1016/j.molcel.2008.06.001
51. R.Kang, H.J.Zeh, M.T.Lotze, D.Tang. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18:571-80; PMID:21311563; http://dx.doi.org/10.1038/cdd.2010.191
52. S.Paillas, A.Causse, L.Marzi, P.de Medina, M.Poirot, V.Denis, N.Vezzio-Vie, L.Espert, H.Arzouk, A.Coquelle, et al. MAPK14/p38alpha confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy 2012; 8:1098-112; PMID:22647487; http://dx.doi.org/10.4161/auto.20268
53. E.Keil, R.Hocker, M.Schuster, F.Essmann, N.Ueffing, B.Hoffman, D.A.Liebermann, K.Pfeffer, K.Schultze-Osthoff, I.Schmitz. Phosphorylation of Atg5 by the Gadd45beta-MEKK4-p38 pathway inhibits autophagy. Cell Death Differ 2013; 20:321-32; PMID:23059785; http://dx.doi.org/10.1038/cdd.2012.129
54. F.Comes, A.Matrone, P.Lastella, B.Nico, F.C.Susca, R.Bagnulo, G.Ingravallo, S.Modica, G.Lo Sasso, A.Moschetta, et al. A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ 2007; 14:693-702; PMID:17159917; http://dx.doi.org/10.1038/sj.cdd.4402076
55. E.Corcelle, N.Djerbi, M.Mari, M.Nebout, C.Fiorini, P.Fenichel, P.Hofman, P.Poujeol, B.Mograbi. Control of the autophagy maturation step by the MAPK ERK and p38:lessons from environmental carcinogens. Autophagy 2007; 3:57-9; PMID:17102581; http://dx.doi.org/10.4161/auto.3424
56. P.W.Schlosshauer, W.Li, K.T.Lin, J.L.Chan, L.H.Wang. Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells. Gynecol Oncol 2009; 114:516-22; PMID:19576622; http://dx.doi.org/10.1016/j.ygyno.2009.06.002
57. S.Mabuchi, T.Hisamatsu, T.Kimura. Targeting mTOR signaling pathway in ovarian cancer. Curr Med Chem 2011; 18:2960-8; PMID:21651485; http://dx.doi.org/10.2174/092986711796150450
58. A.Mansouri, L.D.Ridgway, A.L.Korapati, Q.Zhang, L.Tian, Y.Wang, Z.H.Siddik, G.B.Mills, F.X.Claret. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 2003; 278:19245-56; PMID:12637505; http://dx.doi.org/10.1074/jbc.M208134200
59. G.De Chiara, M.E.Marcocci, M.Torcia, M.Lucibello, P.Rosini, P.Bonini, Y.Higashimoto, G.Damonte, A.Armirotti, S.Amodei, et al. Bcl-2 Phosphorylation by p38 MAPK:identification of target sites and biologic consequences. J Biol Chem 2006; 281:21353-61; PMID:16714293; http://dx.doi.org/10.1074/jbc.M511052200
60. R.K.Srivastava, Q.S.Mi, J.M.Hardwick, D.L.Longo. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci U S A 1999; 96:3775-80; PMID:10097113; http://dx.doi.org/10.1073/pnas.96.7.3775
61. S.Huang, L.Shu, M.B.Dilling, J.Easton, F.C.Harwood, H.Ichijo, P.J.Houghton. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol Cell 2003; 11:1491-501; PMID:12820963; http://dx.doi.org/10.1016/S1097-2765(03)00180-1
62. Y.Yaginuma, H.Westphal. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res 1992; 52:4196-9; PMID:1638534
63. S.J.Mansour, W.T.Matten, A.S.Hermann, J.M.Candia, S.Rong, K.Fukasawa, G.F.Wande Woude, N.G.Ahn. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994; 265:966-70; PMID:8052857; http://dx.doi.org/10.1126/science.8052857
64. J.Kwong, J.Y.Lee, K.K.Wong, X.Zhou, D.T.Wong, K.W.Lo, W.R.Welch, R.S.Berkowitz, S.C.Mok. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia 2006; 8:268-78; PMID:16756719; http://dx.doi.org/10.1593/neo.05502
65. J.Y.Zhou, Y.Liu, G.S.Wu. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Res 2006; 66:4888-94; PMID:16651445; http://dx.doi.org/10.1158/0008-5472.CAN-05-4229